Copyright
©The Author(s) 2022.
World J Transplant. Oct 18, 2022; 12(10): 313-324
Published online Oct 18, 2022. doi: 10.5500/wjt.v12.i10.313
Published online Oct 18, 2022. doi: 10.5500/wjt.v12.i10.313
Table 3 Lymphocyte numbers and subpopulations in panel reactive antibodies (-) and (+) patients at time of transplantation (T0)
| Parameter | T0, at renal transplantation | ||
| All patients | PRA(-) | PRA(+) | |
| n | 71 | 43 | 28 |
| Lymphocyte, % | 18.1 (6.4-40) | 18.8 (6.4-38.4) | 17.8 (11.2-40) |
| Lymphocyte, cells/μL | 1200 (700-2800) | 1200 (700-2800) | 1100 (700-2600) |
| CD4+, % | 42.0 (20.6-68.6) | 44.4 (20.6-68.6) | 41.5 (25.3-59.5) |
| CD4+, cells/μL | 515 (206-1453.2) | 557 (206-1453.2) | 435 (253-1362.4) |
| CD8+, % | 24.55 (10.5-53.1) | 25.1 (12,2-37.7) | 23.4 (10.5-53.1) |
| CD8+, cells/μL | 301.5 (91.7-665.6) | 301.5 (102.9-641.7) | 294.9 (91.7-665.6) |
| CD4+/CD8+ | 1.7 (0.6-5.6) | 1.5 (0.9-5.6) | 2 (0.6-5) |
| CD4+CD28-, % | 5.4 (0.0-33.7) | 4.8 (0.2-33.7) | 7.2 (0-32.1) |
| CD4+CD28-, cells/μL | 26.9 (0.0-206) | 26.7 (0-160) | 27.3 (0-206) |
| CD8+CD28-, % | 38.6 (6.1-91.5) | 38.3 (6.1-68.2) | 48.4 (15.1-91.5) |
| CD8+CD28-, cells/μL | 121.5 (13-583) | 113.6 (17-315) | 122 (13-583) |
| CD16/56, % | 18 (3.6-50.6) | 17.7 (3.6-50.6) | 18.4 (4.4-34.2) |
| CD16/56, cells/μL | 198.1 (50.4-750.5) | 210 (50.4-750.5) | 190.4 (94.8-393.6) |
| Tregs, %, on CD4 | 4 (0.1-11.5) | 3.9 (0.1-11.5) | 4.2 (1.5-7.3) |
| Tregs, cells/μL | 20 (0.52-74.38) | 20.2 (0.5-74.3) | 18.9 (5.8-73.5) |
- Citation: Vagiotas L, Stangou M, Kasimatis E, Xochelli A, Myserlis G, Lioulios G, Nikolaidou V, Panteli M, Ouranos K, Antoniadis N, Maria D, Papagianni A, Tsoulfas G, Fylaktou A. Effect of panel reactive antibodies on T cell immunity reinstatement following renal transplantation. World J Transplant 2022; 12(10): 313-324
- URL: https://www.wjgnet.com/2220-3230/full/v12/i10/313.htm
- DOI: https://dx.doi.org/10.5500/wjt.v12.i10.313